SofWave Medical (SOFW) Planet MicroCap Showcase: VEGAS 2025 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase: VEGAS 2025 summary
3 Feb, 2026Market overview and growth drivers
Non-invasive aesthetic energy device market is rapidly expanding, driven by increased demand for skin tightening and toning, especially due to GLP-1 inhibitor-induced weight loss affecting 12% of the U.S. population.
The addressable market is valued at $2 billion, with high growth rates even during economic downturns.
The technology is used globally in 40+ countries and is recognized by leading practitioners.
Recent FDA clearance in Japan, the world's second-largest non-invasive market, further expands reach.
Recurring revenue model and high ROI for providers, with average payback in 4–6 months.
Technology and innovation
Device uses patented high-intensity, high-frequency ultrasound with unique cooling for safety and efficacy.
Allows for delegatable procedures, reducing physician time and increasing scalability.
Delivers natural-looking results in 1–2 treatments per year, aligning with current aesthetic trends.
Continuous product innovation, including new applicators and modules, expands treatment options and utilization.
Devices are Wi-Fi enabled, supporting ongoing upgrades and data-driven improvements.
Business model and financial performance
Devices sold for ~$100,000, with consumable pulses generating recurring revenue at high gross margins.
Average treatment cost is $2,500–$3,000, with providers achieving 75–80% gross margins.
ROI for providers ranges from 145% to 180% in the first year, significantly outperforming competitors.
Over 425,000 treatments performed, generating $80 million in U.S. provider revenue.
2023 revenue reached $59.7 million, with 19% annual growth and 24% Q4 growth; company is profitable and holds $20 million in cash.
Latest events from SofWave Medical
- Record revenue growth, IFRS profitability, and global expansion driven by recurring revenue.SOFW
Q4 202517 Mar 2026 - Strong growth, high margins, and global expansion fueled by innovative non-invasive technology.SOFW
Jefferies London Healthcare Conference 20253 Feb 2026 - Double-digit growth and high-margin recurring revenue drive global expansion and profitability.SOFW
Stifel 2024 Healthcare Conference13 Jan 2026 - Q3 revenue up 56% year-over-year, driven by recurring sales and new device clearance.SOFW
Q3 202527 Dec 2025 - Rapid growth and high-margin recurring revenue driven by innovative non-invasive technology.SOFW
24th Annual Needham Virtual Healthcare Conference28 Nov 2025 - Q1 revenue up 26% to $16.7M, recurring revenue up 49%, and new Japan market entry.SOFW
Q1 202524 Nov 2025 - Record revenue, strong margins, and positive net income signal robust growth momentum.SOFW
Q2 202523 Nov 2025 - Record recurring revenue and global growth highlight strong demand for non-invasive treatments.SOFW
CG MedTech, Diagnostics and Digital Health & Services Forum20 Nov 2025 - Record growth and profitability driven by recurring revenue and demand for non-invasive treatments.SOFW
Stifel 2025 Healthcare Conference17 Nov 2025